BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 20377268)

  • 1. Molecular mapping of tumor heterogeneity on clinical tissue specimens with multiplexed quantum dots.
    Liu J; Lau SK; Varma VA; Moffitt RA; Caldwell M; Liu T; Young AN; Petros JA; Osunkoya AO; Krogstad T; Leyland-Jones B; Wang MD; Nie S
    ACS Nano; 2010 May; 4(5):2755-65. PubMed ID: 20377268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How often does alpha-methylacyl-CoA-racemase contribute to resolving an atypical diagnosis on prostate needle biopsy beyond that provided by basal cell markers?
    Zhou M; Aydin H; Kanane H; Epstein JI
    Am J Surg Pathol; 2004 Feb; 28(2):239-43. PubMed ID: 15043314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical stains for p63 and alpha-methylacyl-CoA racemase, versus a cocktail comprising both, in the diagnosis of prostatic carcinoma: a comparison of the immunohistochemical staining of 430 foci in radical prostatectomy and needle biopsy tissues.
    Hameed O; Sublett J; Humphrey PA
    Am J Surg Pathol; 2005 May; 29(5):579-87. PubMed ID: 15832080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the basal cell-specific markers, 34betaE12 and p63, in the diagnosis of prostate cancer.
    Shah RB; Zhou M; LeBlanc M; Snyder M; Rubin MA
    Am J Surg Pathol; 2002 Sep; 26(9):1161-8. PubMed ID: 12218572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basal cell cocktail (34betaE12 + p63) improves the detection of prostate basal cells.
    Zhou M; Shah R; Shen R; Rubin MA
    Am J Surg Pathol; 2003 Mar; 27(3):365-71. PubMed ID: 12604893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-methylacyl-CoA racemase: a variably sensitive immunohistochemical marker for the diagnosis of small prostate cancer foci on needle biopsy.
    Magi-Galluzzi C; Luo J; Isaacs WB; Hicks JL; de Marzo AM; Epstein JI
    Am J Surg Pathol; 2003 Aug; 27(8):1128-33. PubMed ID: 12883245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-methylacyl-CoA racemase (P504S)/34betaE12/p63 triple cocktail stain in prostatic adenocarcinoma after hormonal therapy.
    Sung MT; Jiang Z; Montironi R; MacLennan GT; Mazzucchelli R; Cheng L
    Hum Pathol; 2007 Feb; 38(2):332-41. PubMed ID: 17134736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Best practice in diagnostic immunohistochemistry: prostate carcinoma and its mimics in needle core biopsies.
    Paner GP; Luthringer DJ; Amin MB
    Arch Pathol Lab Med; 2008 Sep; 132(9):1388-96. PubMed ID: 18788849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and diagnostic utility of alpha-methylacyl-CoA-racemase (P504S) in foamy gland and pseudohyperplastic prostate cancer.
    Zhou M; Jiang Z; Epstein JI
    Am J Surg Pathol; 2003 Jun; 27(6):772-8. PubMed ID: 12766580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multifunctional quantum dots for cellular and molecular imaging.
    Gao X
    Annu Int Conf IEEE Eng Med Biol Soc; 2007; 2007():524-5. PubMed ID: 18002008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. alpha-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer.
    Rubin MA; Zhou M; Dhanasekaran SM; Varambally S; Barrette TR; Sanda MG; Pienta KJ; Ghosh D; Chinnaiyan AM
    JAMA; 2002 Apr; 287(13):1662-70. PubMed ID: 11926890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant diffuse expression of p63 in adenocarcinoma of the prostate on needle biopsy and radical prostatectomy: report of 21 cases.
    Osunkoya AO; Hansel DE; Sun X; Netto GJ; Epstein JI
    Am J Surg Pathol; 2008 Mar; 32(3):461-7. PubMed ID: 18300803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can basal cells be seen in adenocarcinoma of the prostate?: an immunohistochemical study using high molecular weight cytokeratin (clone 34betaE12) antibody.
    Oliai BR; Kahane H; Epstein JI
    Am J Surg Pathol; 2002 Sep; 26(9):1151-60. PubMed ID: 12218571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of annexin II, p63 and alpha-methylacyl-CoA racemase immunoreactivity in prostatic tissue: a tissue microarray study.
    Stewart J; Fleshner N; Cole H; Sweet J
    J Clin Pathol; 2007 Jul; 60(7):773-80. PubMed ID: 16916997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo cancer targeting and imaging with semiconductor quantum dots.
    Gao X; Cui Y; Levenson RM; Chung LW; Nie S
    Nat Biotechnol; 2004 Aug; 22(8):969-76. PubMed ID: 15258594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic utility of p63 and α-methyl acyl Co A racemase in resolving suspicious foci in prostatic needle biopsy and transurethral resection of prostate specimens.
    Singh V; Manu V; Malik A; Dutta V; Mani NS; Patrikar S
    J Cancer Res Ther; 2014; 10(3):686-92. PubMed ID: 25313761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular profiling of single cancer cells and clinical tissue specimens with semiconductor quantum dots.
    Xing Y; Smith AM; Agrawal A; Ruan G; Nie S
    Int J Nanomedicine; 2006; 1(4):473-81. PubMed ID: 17722280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell type specific gene expression analysis of prostate needle biopsies resolves tumor tissue heterogeneity.
    Krönig M; Walter M; Drendel V; Werner M; Jilg CA; Richter AS; Backofen R; McGarry D; Follo M; Schultze-Seemann W; Schüle R
    Oncotarget; 2015 Jan; 6(2):1302-14. PubMed ID: 25514598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of racemase and other immunomarkers in the detection of adenocarcinoma in prostatic tissue damaged by high intensity focused ultrasound therapy.
    Dalfior D; Delahunt B; Brunelli M; Parisi A; Ficarra V; Novara G; Novella G; Gobbo S; Valotto C; Chilosi M; Menestrina F; Martignoni G
    Pathology; 2010 Jan; 42(1):1-5. PubMed ID: 20025473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 34BetaE12 and Alfa-Methylacyl Coenzyme A Racemase (AMACR) Antibodies Better Than p63 Antibody Distinguish Normal and Neoplastic Glands in Prostatic Tissue With Thermal Artifacts.
    Pierconti F; Rossi ED; Martini M; Sacco E; Bassi PF; Larocca LM
    Appl Immunohistochem Mol Morphol; 2019 Apr; 27(4):306-310. PubMed ID: 29346181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.